Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: an Italian randomized clinical trial.

PLoS One · 2013 · PMC3828227 · PMID 24244635

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

an increasing trendp=.055so close (0.05 < p ≤ 0.1)

IL-7/IL-7R system Arm A displayed an increasing trend in CD127+CD4+ T-cells, close to statistical significance at w12 (T0, 69 [54.9-82.3]%, w12, 74.2 [58.1-82.8]%, w48 80.9 [63.2-89.3]%; p=.055 for T0 vs w12; p=.46 for T0 vs w48), whereas no changes was shown over time in arm B (T0, 59.2 [41.2-81.1], w12, 65.5 [52.4-70.4]%, w48, 80.7 [62.3-83.4]%, p=.39 for T0 vs w12, p=.16 forT0 vs w48) ( Figure 5A ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.